Literature DB >> 21987229

Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus.

Gang Wang1, Lai-Shan Tam, Bonnie Ching-Ha Kwan, Edmund Kwok-Ming Li, Kai-Ming Chow, Cathy Choi-Wan Luk, Philip Kam-Tao Li, Cheuk-Chun Szeto.   

Abstract

We studied the levels of miR-146a and miR-155 in the urine sediment of SLE patients. The levels of miR-146a and miR-155 in the urine sediment of 40 SLE patients who were receiving calcitriol treatment and 13 healthy controls were determined with real-time quantitative polymerase chain reaction. The levels of urinary miR-146a and miR-155 in patients with SLE were significantly higher than that in healthy controls. Calcitriol treatment reduced the levels of urinary miR-155 in patients with SLE. The level of urinary miR-146a significantly correlated with estimated glomerular filtration rate (r = 0.242, P = 0.008). The level of urinary miR-155 significantly correlated with proteinuria (r = 0.407, P < 0.001) and systemic lupus erythematosus disease activity index (r = 0.278, P = 0.002). The level of urinary miR-146a reversely correlated with the urinary expression of TNF-α (r = -0.247, P = 0.012). Our results suggested that miR-146a and miR-155 might play important roles in the pathophysiology of SLE and the levels of urinary miR-146a and miR-155 could be used as potential markers for diagnosis, disease activity, and therapeutic response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987229     DOI: 10.1007/s10067-011-1857-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

Review 1.  Systemic lupus erythematosus.

Authors:  Anisur Rahman; David A Isenberg
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 2.  MicroRNA control in the immune system: basic principles.

Authors:  Changchun Xiao; Klaus Rajewsky
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

Review 3.  Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.

Authors:  H Terence Cook; Marina Botto
Journal:  Nat Clin Pract Rheumatol       Date:  2006-06

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Intrarenal cytokine gene expression in lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Kai-Ming Chow; Ka-Bik Lai; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

6.  Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Teresa Yuk-Hwa Wong; Carol Yi-Ki Szeto; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Arthritis Rheum       Date:  2004-09

7.  Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells.

Authors:  A W Pedersen; K Holmstrøm; S S Jensen; D Fuchs; S Rasmussen; P Kvistborg; M H Claesson; M-B Zocca
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

8.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

9.  Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients.

Authors:  Kaleb M Pauley; Minoru Satoh; Annie L Chan; Michael R Bubb; Westley H Reeves; Edward Kl Chan
Journal:  Arthritis Res Ther       Date:  2008-08-29       Impact factor: 5.156

Review 10.  microRNAs: a new emerging class of players for disease diagnostics and gene therapy.

Authors:  Baohong Zhang; M A Farwell
Journal:  J Cell Mol Med       Date:  2007-12-14       Impact factor: 5.310

View more
  30 in total

1.  Is serum microRNA better specific marker for systemic lupus erythematosus?

Authors:  Man-Man Lu; Rui-Xue Leng; Wang-Dong Xu; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2012-05-25       Impact factor: 2.980

2.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

Review 3.  Noninvasive micromarkers.

Authors:  Janani Saikumar; Krithika Ramachandran; Vishal S Vaidya
Journal:  Clin Chem       Date:  2014-01-09       Impact factor: 8.327

Review 4.  The beneficial role of vitamin D in systemic lupus erythematosus (SLE).

Authors:  Khanh vinh quốc Luong; Lan Thi Hoàng Nguyễn
Journal:  Clin Rheumatol       Date:  2012-07-17       Impact factor: 2.980

Review 5.  Diagnostic and prognostic tests in systemic lupus erythematosus.

Authors:  Natalia Vasquez-Canizares; Dawn Wahezi; Chaim Putterman
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-06       Impact factor: 4.098

6.  Stability of miRNA in human urine supports its biomarker potential.

Authors:  Christine Mall; David M Rocke; Blythe Durbin-Johnson; Robert H Weiss
Journal:  Biomark Med       Date:  2013-08       Impact factor: 2.851

Review 7.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

8.  MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression.

Authors:  Ruozhen Hu; Thomas B Huffaker; Dominique A Kagele; Marah C Runtsch; Erin Bake; Aadel A Chaudhuri; June L Round; Ryan M O'Connell
Journal:  J Immunol       Date:  2013-05-17       Impact factor: 5.422

Review 9.  The pathogenesis, diagnosis and treatment of lupus nephritis.

Authors:  Noa Schwartz; Beatrice Goilav; Chaim Putterman
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

Review 10.  Contribution of MicroRNAs to autoimmune diseases.

Authors:  Lucien P Garo; Gopal Murugaiyan
Journal:  Cell Mol Life Sci       Date:  2016-03-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.